Adult attention-deficit/hyperactivity disorder quality of life questionnaire (AAQoL): systematic review

Detalhes bibliográficos
Autor(a) principal: Alves, Mylena Aparecida Rodrigues
Data de Publicação: 2019
Outros Autores: Ohata, Ana Paula Almeida Rocha, Pochapski, Marcia Thaís, Pinto, Márcia Helena Baldani, Pedroso, Bruno
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Brasileira de Qualidade de Vida
Texto Completo: https://periodicos.utfpr.edu.br/rbqv/article/view/9895
Resumo: OBJECTIVE: The present research aimed to systematically analyze the use of medicines that improve the quality of life in adults with ADHD, measured through the specific tool (AAQoL).METHODS: This systematic review study was sectioned into the following steps: research question formulation, literature search, article selection, data extraction, data synthesis, quality of evidence evaluation and writing, and publication of results.RESULTS: The studies selected to compose the systematic review demonstrated the commitment associated with the presence of ADHD in adult life, taking as intervention the medication in studies of quality. Thus, based on the evaluation proposed by the Cochrane Collaboration tool, it is possible to show that quality of life can be improved by the use of drugs that control symptoms in adults with ADHD.CONCLUSIONS: Clinical studies have proved significant improvement of the patients’ quality of life using specific ADHD medicines, as Atomoxetine, extended-release Methylphenidate and Metadoxine.
id UTFPR-9_8579e52e16b71783d721d2114b913454
oai_identifier_str oai:periodicos.utfpr:article/9895
network_acronym_str UTFPR-9
network_name_str Revista Brasileira de Qualidade de Vida
repository_id_str
spelling Adult attention-deficit/hyperactivity disorder quality of life questionnaire (AAQoL): systematic reviewQuestionário de qualidade de vida em adultos com transtorno do déficit de atenção com hiperatividade (AAQOL): revisão sistemáticaCiências da Saúde; Saúde ColetivaAAQoL; Adultos; TDAH; Medicamentos.AAQoL; Adults; ADHD; Medicines.OBJECTIVE: The present research aimed to systematically analyze the use of medicines that improve the quality of life in adults with ADHD, measured through the specific tool (AAQoL).METHODS: This systematic review study was sectioned into the following steps: research question formulation, literature search, article selection, data extraction, data synthesis, quality of evidence evaluation and writing, and publication of results.RESULTS: The studies selected to compose the systematic review demonstrated the commitment associated with the presence of ADHD in adult life, taking as intervention the medication in studies of quality. Thus, based on the evaluation proposed by the Cochrane Collaboration tool, it is possible to show that quality of life can be improved by the use of drugs that control symptoms in adults with ADHD.CONCLUSIONS: Clinical studies have proved significant improvement of the patients’ quality of life using specific ADHD medicines, as Atomoxetine, extended-release Methylphenidate and Metadoxine.OBJETIVO: Analisar sistematicamente o uso de medicamentos que melhorem a qualidade de vida em adultos com transtorno do déficit de atenção com hiperatividade (TDAH) mensurada por meio de um instrumento específico (AAQoL).MÉTODOS: O presente estudo de revisão sistemática foi seccionado nas seguintes etapas: elaboração da pergunta de pesquisa, busca na literatura, seleção dos artigos, extração dos dados, síntese dos dados, avaliação da qualidade das evidências e redação, e publicação dos resultados.RESULTADOS: Os estudos selecionados para a composição da revisão sistemática, demonstraram o comprometimento associado à presença do TDAH na vida adulta, tendo como intervenção a medicação em estudos caracterizados de qualidade. Com base na avaliação proposta pela ferramenta Cochrane de colaboração, é possível evidenciar que a qualidade de vida foi melhorada com a utilização de fármacos que controlam os sintomas em adultos com TDAH.CONCLUSÕES: Estudos clínicos comprovam melhora significativa da qualidade de vida dos pacientes com o uso de medicações específicas para TDAH, como Atomoxetina, Metilfenidato de ação prolongada e Metadoxina de liberação prolongada.Universidade Tecnológica Federal do Paraná (UTFPR)CNPqAlves, Mylena Aparecida RodriguesOhata, Ana Paula Almeida RochaPochapski, Marcia ThaísPinto, Márcia Helena BaldaniPedroso, Bruno2019-10-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.utfpr.edu.br/rbqv/article/view/989510.3895/rbqv.v11n3.9895Revista Brasileira de Qualidade de Vida; v. 11, n. 3 (2019)2175-085810.3895/rbqv.v11n3reponame:Revista Brasileira de Qualidade de Vidainstname:Universidade Tecnológica Federal do Paraná (UTFPR)instacron:UTFPRporhttps://periodicos.utfpr.edu.br/rbqv/article/view/9895/pdfDireitos autorais 2019 CC-BYhttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccess2019-11-18T21:51:22Zoai:periodicos.utfpr:article/9895Revistahttps://periodicos.utfpr.edu.br/rbqvPUBhttp://periodicos.utfpr.edu.br/rbqv/oai||rbqv-pg@utfpr.edu.br2175-08582175-0858opendoar:2019-11-18T21:51:22Revista Brasileira de Qualidade de Vida - Universidade Tecnológica Federal do Paraná (UTFPR)false
dc.title.none.fl_str_mv Adult attention-deficit/hyperactivity disorder quality of life questionnaire (AAQoL): systematic review
Questionário de qualidade de vida em adultos com transtorno do déficit de atenção com hiperatividade (AAQOL): revisão sistemática
title Adult attention-deficit/hyperactivity disorder quality of life questionnaire (AAQoL): systematic review
spellingShingle Adult attention-deficit/hyperactivity disorder quality of life questionnaire (AAQoL): systematic review
Alves, Mylena Aparecida Rodrigues
Ciências da Saúde; Saúde Coletiva
AAQoL; Adultos; TDAH; Medicamentos.
AAQoL; Adults; ADHD; Medicines.
title_short Adult attention-deficit/hyperactivity disorder quality of life questionnaire (AAQoL): systematic review
title_full Adult attention-deficit/hyperactivity disorder quality of life questionnaire (AAQoL): systematic review
title_fullStr Adult attention-deficit/hyperactivity disorder quality of life questionnaire (AAQoL): systematic review
title_full_unstemmed Adult attention-deficit/hyperactivity disorder quality of life questionnaire (AAQoL): systematic review
title_sort Adult attention-deficit/hyperactivity disorder quality of life questionnaire (AAQoL): systematic review
author Alves, Mylena Aparecida Rodrigues
author_facet Alves, Mylena Aparecida Rodrigues
Ohata, Ana Paula Almeida Rocha
Pochapski, Marcia Thaís
Pinto, Márcia Helena Baldani
Pedroso, Bruno
author_role author
author2 Ohata, Ana Paula Almeida Rocha
Pochapski, Marcia Thaís
Pinto, Márcia Helena Baldani
Pedroso, Bruno
author2_role author
author
author
author
dc.contributor.none.fl_str_mv
CNPq
dc.contributor.author.fl_str_mv Alves, Mylena Aparecida Rodrigues
Ohata, Ana Paula Almeida Rocha
Pochapski, Marcia Thaís
Pinto, Márcia Helena Baldani
Pedroso, Bruno
dc.subject.por.fl_str_mv Ciências da Saúde; Saúde Coletiva
AAQoL; Adultos; TDAH; Medicamentos.
AAQoL; Adults; ADHD; Medicines.
topic Ciências da Saúde; Saúde Coletiva
AAQoL; Adultos; TDAH; Medicamentos.
AAQoL; Adults; ADHD; Medicines.
description OBJECTIVE: The present research aimed to systematically analyze the use of medicines that improve the quality of life in adults with ADHD, measured through the specific tool (AAQoL).METHODS: This systematic review study was sectioned into the following steps: research question formulation, literature search, article selection, data extraction, data synthesis, quality of evidence evaluation and writing, and publication of results.RESULTS: The studies selected to compose the systematic review demonstrated the commitment associated with the presence of ADHD in adult life, taking as intervention the medication in studies of quality. Thus, based on the evaluation proposed by the Cochrane Collaboration tool, it is possible to show that quality of life can be improved by the use of drugs that control symptoms in adults with ADHD.CONCLUSIONS: Clinical studies have proved significant improvement of the patients’ quality of life using specific ADHD medicines, as Atomoxetine, extended-release Methylphenidate and Metadoxine.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-31
dc.type.none.fl_str_mv
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.utfpr.edu.br/rbqv/article/view/9895
10.3895/rbqv.v11n3.9895
url https://periodicos.utfpr.edu.br/rbqv/article/view/9895
identifier_str_mv 10.3895/rbqv.v11n3.9895
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.utfpr.edu.br/rbqv/article/view/9895/pdf
dc.rights.driver.fl_str_mv Direitos autorais 2019 CC-BY
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos autorais 2019 CC-BY
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Tecnológica Federal do Paraná (UTFPR)
publisher.none.fl_str_mv Universidade Tecnológica Federal do Paraná (UTFPR)
dc.source.none.fl_str_mv Revista Brasileira de Qualidade de Vida; v. 11, n. 3 (2019)
2175-0858
10.3895/rbqv.v11n3
reponame:Revista Brasileira de Qualidade de Vida
instname:Universidade Tecnológica Federal do Paraná (UTFPR)
instacron:UTFPR
instname_str Universidade Tecnológica Federal do Paraná (UTFPR)
instacron_str UTFPR
institution UTFPR
reponame_str Revista Brasileira de Qualidade de Vida
collection Revista Brasileira de Qualidade de Vida
repository.name.fl_str_mv Revista Brasileira de Qualidade de Vida - Universidade Tecnológica Federal do Paraná (UTFPR)
repository.mail.fl_str_mv ||rbqv-pg@utfpr.edu.br
_version_ 1787713860719869952

Registros relacionados